Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion

Author Correction: Differential epigenetic

reprogramming in response to speci fi c endocrine therapies promotes cholesterol biosynthesis and cellular invasion

Van T.M. Nguyen ^1,8 , Iros Barozzi ^2,8 , Monica Faronato ¹ , Ylenia Lombardo ¹ , Jennifer H. Steel ¹ , Naina Patel ¹ , Philippa Darbre ³ , Leandro Castellano ¹ , Balázs Gy ő rffy ^4,5 , Laura Woodley ⁶ , Alba Rodriguez-Meira ¹ ,

Darren K. Patten ¹ , Valentina Vircillo ⁷ , Manikandan Periyasamy ¹ , Simak Ali ¹ , Gianmaria Frige ² , Saverio Minucci ² , R. Charles Coombes ¹ & Luca Magnani ¹

Correction to: Nature Communications https://doi.org/10.1038/ncomms10044, published online 27 November 2015

This Article omits a declaration from the Competing Interests statement, which should have included the following: ‘One of the authors, Y.L., is an editor on the staff of Nature Communications, but was not in any way involved in the journal review process. The other authors declare no competing interests.’

Also, the Article contains an error in the name of the author Alba Rodriguez-Meira, which is incorrectly given as Alba Meira.

These errors have not been corrected in either the PDF or HTML versions of the Article.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visithttp://creativecommons.org/licenses/by/4.0/.

© The Author(s) 2019

https://doi.org/10.1038/s41467-019-11569-z

OPEN

1Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK.²IFOM-IEO Campus, European Institute of Oncology, Milan 20139, Italy.³School of Biological Science, University of Reading, Reading RG6 6LA, UK.⁴MTATTK Lendület Cancer Biomarker Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest H-1117, Hungary.⁵MTA-SE Pediatrics and Nephrology Research Group, 2nd Department of Pediatrics, Semmelweis University, Budapest H-1117, Hungary.⁶ECMC, Charing Cross Hospital, London W120nn, UK.⁷Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata di Rende (CS) 87036, Italy.⁸These authors contributed equally: Van T. M. Nguyen, Iros Barozzi. Correspondence and requests for materials should be addressed to L.M. (email:l.magnani@imperial.ac.uk)

NATURE COMMUNICATIONS| (2019) 10:3505 | https://doi.org/10.1038/s41467-019-11569-z | www.nature.com/naturecommunications 1

1234567890():,;